Expanded Access to NanoDoce

Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00003562 ·Status: UNKNOWN ·Phase: PHASE2

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

NCT04055753 ·Status: ACTIVE_NOT_RECRUITING

A Study of Ramucirumab (LY3009806) in Combination With Weekly Docetaxel in Participants With Stage IV Non-Small Cell Lung Cancer

NCT02831491 ·Status: WITHDRAWN ·Phase: PHASE2

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

NCT04430933 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients

NCT02066103 ·Status: COMPLETED ·Phase: NA

Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer

NCT01107444 ·Status: COMPLETED ·Phase: PHASE2

Organoid-guided vs Topotecan Therapy in Relapsed Extensive-Stage Small Cell Lung Cancer

NCT07106528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery

NCT02888665 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax

NCT00826852 ·Status: COMPLETED ·Phase: PHASE2

A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)

NCT00461110 ·Status: TERMINATED ·Phase: PHASE1

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

NCT01465802 ·Status: COMPLETED ·Phase: PHASE2

Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase

NCT06961201 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes

NCT01159288 ·Status: COMPLETED ·Phase: PHASE2

Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)

NCT00682383 ·Status: COMPLETED ·Phase: PHASE2

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

NCT05275868 ·Status: TERMINATED ·Phase: PHASE1

Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer

NCT00362882 ·Status: COMPLETED ·Phase: PHASE2

The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)

NCT00887315 ·Status: TERMINATED ·Phase: PHASE2

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer

NCT01620190 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY2940680 in Small Cell Lung Cancer

NCT01722292 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)

NCT03420014 ·Status: RECRUITING ·Phase: PHASE2

A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

NCT04420884 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT02588612 ·Status: COMPLETED ·Phase: PHASE1

E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT00832819 ·Status: COMPLETED ·Phase: PHASE1

Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer

NCT06928389 ·Status: RECRUITING ·Phase: PHASE3

Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)

NCT01432483 ·Status: NO_LONGER_AVAILABLE